Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea M Collins

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
American Journal of Respiratory and Critical Care Medicine|September 17, 2020
Experimental Human Pneumococcal Colonization in Older Adults Is Feasible and Safe, Not ImmunogenicHugh Adler, Esther L German, Elena Mitsi, et al.
The Journal of Clinical Investigation|June 1, 2022
Innate and adaptive nasal mucosal immune responses following experimental human pneumococcal colonizationSimon P Jochems, Karin de Ruiter, Carla Solórzano, et al.
The Journal of Clinical Investigation|July 31, 2019
Innate and adaptive nasal mucosal immune responses following experimental human pneumococcal colonizationSimon P Jochems, Karin de Ruiter, Carla Solórzano, et al.
The Journal of Infection|December 15, 2021
Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodiesSophie I Owen, Christopher T Williams, Gala Garrod, et al.
American Journal of Respiratory and Critical Care Medicine|August 9, 2023
A Randomized Controlled Clinical Trial of Nasal Immunization with Live Virulence Attenuated <i>Streptococcus pneumoniae</i> Strains Using Human Infection ChallengeHelen Hill, Elena Mitsi, Elissavet Nikolaou, et al.
Plos One|July 1, 2025
Understanding the interaction of upper respiratory tract infection with respiratory syncytial virus and Streptococcus pneumoniae using a human challenge model: a multicenter, randomized controlled study protocolSanjita Brito-Mutunayagam, David O Hamilton, Elena Mitsi, et al.
The Journal of Clinical Investigation|February 9, 2022
Streptococcus pneumoniae colonization associates with impaired adaptive immune responses against SARS-CoV-2Elena Mitsi, Jesús Reiné, Britta C Urban, et al.
American Journal of Respiratory and Critical Care Medicine|July 8, 2022
Human Infection Challenge with Serotype 3 PneumococcusRyan E Robinson, Elena Mitsi, Elissavet Nikolaou, et al.
Cell Reports|May 26, 2026
Host-microbial interactions at the nasal mucosa in young children and adults: A retrospective, cross-sectional studyJesús Reiné, Lisa A King, Youvika Singh, et al.
Lancet (London, England)|August 9, 2021
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trialXinxue Liu, Robert H Shaw, Arabella S V Stuart, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
American Journal of Respiratory and Critical Care Medicine|September 17, 2020
Experimental Human Pneumococcal Colonization in Older Adults Is Feasible and Safe, Not ImmunogenicHugh Adler, Esther L German, Elena Mitsi, et al.
The Journal of Clinical Investigation|June 1, 2022
Innate and adaptive nasal mucosal immune responses following experimental human pneumococcal colonizationSimon P Jochems, Karin de Ruiter, Carla Solórzano, et al.
The Journal of Clinical Investigation|July 31, 2019
Innate and adaptive nasal mucosal immune responses following experimental human pneumococcal colonizationSimon P Jochems, Karin de Ruiter, Carla Solórzano, et al.
The Journal of Infection|December 15, 2021
Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodiesSophie I Owen, Christopher T Williams, Gala Garrod, et al.
American Journal of Respiratory and Critical Care Medicine|August 9, 2023
A Randomized Controlled Clinical Trial of Nasal Immunization with Live Virulence Attenuated <i>Streptococcus pneumoniae</i> Strains Using Human Infection ChallengeHelen Hill, Elena Mitsi, Elissavet Nikolaou, et al.
Plos One|July 1, 2025
Understanding the interaction of upper respiratory tract infection with respiratory syncytial virus and Streptococcus pneumoniae using a human challenge model: a multicenter, randomized controlled study protocolSanjita Brito-Mutunayagam, David O Hamilton, Elena Mitsi, et al.
The Journal of Clinical Investigation|February 9, 2022
Streptococcus pneumoniae colonization associates with impaired adaptive immune responses against SARS-CoV-2Elena Mitsi, Jesús Reiné, Britta C Urban, et al.
American Journal of Respiratory and Critical Care Medicine|July 8, 2022
Human Infection Challenge with Serotype 3 PneumococcusRyan E Robinson, Elena Mitsi, Elissavet Nikolaou, et al.
Cell Reports|May 26, 2026
Host-microbial interactions at the nasal mucosa in young children and adults: A retrospective, cross-sectional studyJesús Reiné, Lisa A King, Youvika Singh, et al.
Lancet (London, England)|August 9, 2021
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trialXinxue Liu, Robert H Shaw, Arabella S V Stuart, et al.
Pageof 6